EU-funded projects - Pure Biologics - Harnessing the power of antibodies and aptamers

 PB003G

Developing a therapy that recruits the immune system to fight cancer and specifically targets the GARP-TGFβ1 complex

Development of anticancer drug based on anti-ROR1 antibody

Development of the bispecific antibody for the immunotherapy

Development of the first in class therapeutic device for use in the treatment of autoimmune neurodegenerative disease

Developing a therapy that recruits the immune system to fight cancer and specifically targets integrin αVβ8

Development of the first-in-class therapeutic medical device indicated to use during myasthenic crisis in myasthenia gravis patients

Development of new melanoma therapy based on aptamer carrier

Molecular Analytical Robotics Assays

New MAGnetic Biomaterials for Brain Repair and Imaging after Stroke

The creation of a collection of phages specific for pathogens causing honeybee foulbrood